Hot Undervalued Stocks To Own For 2019

Generating alpha in today’s market is quite challenging. With the speed that information is disseminated it has become difficult to find undervalued opportunities to achieve outsized returns; once news becomes public, a stock quickly is re-priced to reflect this new information. In today’s highly competitive environment, the way to beat the market is to put disparate pieces of information together to paint a picture of what might be coming down the pipe.

Prior Examples

Glu Mobile (GLUU) Example

My article on GLUU provides a good example of how I pieced together disparate pieces of information to generate alpha. In my article entitled Glu Mobile: A Stock Darling for 2017, I outlined several factors that were contributing to the stock trading at a significantly undervalued level. These factors included: tax loss harvesting, investors not pricing in the value of GLUU’s evergreen strategy, GLUU’s short interest level, and strong insider buying.

Each of these factors in isolation didn’t provide a compelling narrative as to GLUU’s potential, but by putting them all together one is able to see why the stock might be temporarily trading at a depressed level. At the time of publishing, GLUU was trading at $1.94 per share and I suggested investors take their profits in August at $3.15 per share–although this was a bit too early since the stock is currently trading at $5.76 per share. Nonetheless, this anecdote provides evidence about how it is still possible to do a deep dive on a company and glean insight into why the market may be myopically viewing a stock.

Hot Undervalued Stocks To Own For 2019: RAIT Financial Trust(RAS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    RAIT Financial Trust (NYSE:RAS) will announce its earnings results before the market opens on Wednesday, May 23rd. Analysts expect the company to announce earnings of $0.21 per share for the quarter.

Hot Undervalued Stocks To Own For 2019: 1st Source Corporation(SRCE)

Advisors’ Opinion:

  • [By ]

    Currently, I like People’s Utah Bancorp (Nasdaq: PUB), 1st Source Corporation (Nasdaq: SRCE), and East West Bancorp (Nasdaq: EWBC) as stocks likely to benefit in the small/regional sector.

  • [By Max Byerly]

    1st Source (NASDAQ:SRCE)’s share price hit a new 52-week high and low during mid-day trading on Thursday . The stock traded as low as $56.13 and last traded at $55.94, with a volume of 100 shares changing hands. The stock had previously closed at $55.94.

  • [By Max Byerly]

    1st Source Co. (NASDAQ:SRCE) has been assigned a consensus rating of “Hold” from the six analysts that are presently covering the stock, Marketbeat.com reports. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12 month target price among analysts that have covered the stock in the last year is $55.00.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on 1st Source (SRCE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Undervalued Stocks To Own For 2019: Gilead Sciences, Inc.(GILD)

Advisors’ Opinion:

  • [By Logan Wallace]

    KBC Group NV trimmed its stake in Gilead Sciences, Inc. (NASDAQ:GILD) by 10.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 227,921 shares of the biopharmaceutical company’s stock after selling 27,406 shares during the period. KBC Group NV’s holdings in Gilead Sciences were worth $17,183,000 at the end of the most recent quarter.

  • [By Todd Campbell]

    Sangamo Therapeutics has alsoinked a collaborationwith Gilead Sciences (NASDAQ:GILD)to work on ZFN approaches that may improve cancer treatment. As part of that deal, Sangamo received an upfront payment of $150 million from Gilead Sciences and it could receive up to $3.01 billion in potential milestones. If any therapies from this collaboration win approval, then Sangamo will receive tiered royalties on future sales.

  • [By Cory Renauer]

    Biotech traders get heaps of attention, but buying promising young drugmakers and holding them for the long term is a far easier way to get rich. Case in point: Spreading $10,000 evenly among shares of Biogen Inc. (NASDAQ:BIIB),Celgene Corporation (NASDAQ:CELG), andGilead Sciences Inc.(NASDAQ:GILD) around this time in 1998 would have made you a millionaire already.

  • [By Matthew Cochrane]

    A value trap is a stock that appears to be cheap but, in reality, is not because of deteriorating business conditions. Examples of traps include pharmaceutical companies with a valuable patent set to expire, cyclical stocks at the peak of the cycle, or tech stocks in the midst of having their expertise being commoditized away. Unfortunately, this is a pitfall I have firsthand experience with. In early 2016, I bought shares of Gilead Sciences, Inc. (NASDAQ: GILD) for just under $93. At the time, Gilead’s trailing twelve months EPS was $11.74 giving it what I thought was a dirt cheap P/E ratio of 7.9 — I thought shares were a steal.

Hot Undervalued Stocks To Own For 2019: Student Transportation Inc(STB)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Student Transportation (STB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    That was certainly the case with Student Transportation (NYSE: STB). My former High-Yield Investing holding was trading at $6.00 per share at the closing bell on February 27. The next morning, it opened near $7.50 following a surprise takeover offer from a privately held Canadian company — giving us a nice 25% gain overnight.

  • [By ]

    One of the main goals of my premium newsletter High-Yield Investing is stability. I like industries that don’t go through unpredictable hot and cold cycles. Student Transportation (NYSE: STB) is a textbook example.

Hot Undervalued Stocks To Own For 2019: CSP Inc.(CSPI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Headlines about CSP (NASDAQ:CSPI) have been trending somewhat positive this week, according to Accern. The research firm identifies negative and positive media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. CSP earned a news sentiment score of 0.07 on Accern’s scale. Accern also gave headlines about the information technology services provider an impact score of 44.9831568716707 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Leave a Reply

Your email address will not be published. Required fields are marked *